Jane McKenzie

5PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 05, 2026
Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer.

|Apr 01, 2026
Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial).

Santosh Gupta, Siyuan Guo, Susan Halabi

|Mar 08, 2025
Preventive medication deprescribing in advanced cancer patients approaching end of life.

Jane McKenzie, Catherine Dunn, Grace Gard

|May 15, 2024
Case of the month from the Department of Medical Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Australia: recurrent metastatic spermatocytic tumour successfully treated with salvage systemic chemotherapy.

Jane McKenzie, Catherine Mitchell, Jeremy Lewin

|Mar 19, 2024
Primary thoracic aorta angiosarcoma presenting with thromboembolism and progressive claudication despite anticoagulation.

Jane McKenzie, Sarat Chander, Catherine Mitchell

Pageof 1

Frequent Collaborators

2 joint publications

Daniel J George

2 joint publications

Andrew J Armstrong

1 joint publications

Jeremy Lewin

1 joint publications

Ciara Conduit